Medicare reform among US medical technology industry's plans and goals for 2006
This article was originally published in Clinica
Executive Summary
Top officials at the US medtech industry association, AdvaMed, have announced an ambitious list of goals for 2006 that includes two legislative proposals - reforming Medicare's reimbursement for clinical laboratory services and ensuring that it appropriately pays for remote patient monitoring systems. These and other initiatives aimed at promoting adequate payment for medical technology are among five areas that the trade association calls its "innovation agenda".
You may also be interested in...
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.